Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
21 Jul 2021
21 Jul 2021
Historique:
entrez:
27
7
2021
pubmed:
28
7
2021
medline:
28
7
2021
Statut:
epublish
Résumé
SARS-CoV-2 infections elicit both humoral and cellular immune responses. For the prevention and treatment of COVID19, the disease caused by SARS-CoV-2, T cell responses are important in mediating recovery and immune-protection. The identification of immunogenic epitopes that can elicit a meaningful T cell response can be elusive. Traditionally, this has been achieved using sophisticated Current state of the art uses putative epitope peptides based on
Identifiants
pubmed: 34312620
doi: 10.1101/2021.07.20.453160
pmc: PMC8312890
pii:
doi:
Types de publication
Preprint
Langues
eng